Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by craighenryon Jan 16, 2023 8:58pm
97 Views
Post# 35226927

RE:RE:RE:RE:RE:RE:RE:Support

RE:RE:RE:RE:RE:RE:RE:Support
craighenry wrote:
Boomskid wrote: Hey, Craig. What do you think of poof's contention that Bioasis acquired Midatech? Do you suppose very many shareholders agree with him?

Good one, huh?

Explains why he only gets 0.8 of a thumb per post. (I get 3.5 thumbs.)

I have posted 189 times in 27 days, exatly 7 posts a day during these important times.

It's all about the message, Craig.

I just write 'em. I don't click 'em.

It's a signal, boyz. Shareholders are not happy.

jd



You're irrelevant quacko!

Only 1 or 2 people maybe 3 at most give you a thumbs up.  And those individuals are clueless about the market and trading in general. 
They dont have  the ability to research on their own,  so they come here to be spoon fed by you.

Those same individuals lost 85% of their hard earned money listening to you. 

I van assure you POF doesn't give a poop about thumbs up.  He can pay his bills!


As for what POF said, I could careless. 


I have better things to do with my time than to pick his post apart.  I am getting ready for tomorrows market open.

What set ups look good after the holiday today?

What will tomorrow bring for CYCN and the Slate Path saga that had a twist on Friday AH?

Looking at the DOW pre market it might be a red day tomorrow.  Only down 60 points which is nothing. 

Those kind of things that traders / investors should be doing. 



But, you wouldn't have a clue JBroke.

Keep telling yourself how "relevant " you are because you get so many thumbs up!!!

LMFAO






The other thing I am looking into right now is WNDR and the likelihood of a merge/takeover by Coinsquare.

WNDR trades at about .80 cents share book value.

What premium would WNDR be taken out at?

2 times?
3 times?



Yeah.... JBroke.


Those are the kind of things Im looking at.


Not about how many thumbs up myself or others get.



<< Previous
Bullboard Posts
Next >>